Outcome and prognostic factors for patients with non-small-cell lung cancer and severe radiation pneumonitis

Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):735-41. doi: 10.1016/s0360-3016(02)02994-2.

Abstract

Purpose: Radiation pneumonitis is a serious complication that develops after thoracic irradiation. The purpose of this study was to identify prognostic factors for severe radiation pneumonitis in patients with non-small-cell lung cancer.

Methods and materials: The medical records of patients with non-small-cell lung cancer and severe radiation pneumonitis were reviewed. Variables were analyzed by univariate and stepwise multivariate analysis using the Cox regression model.

Results: Among the 31 patients, the mortality rate approached 50% in the first 2 months after the onset of radiation pneumonitis. The variables significantly associated with survival in the univariate analysis were tumor histologic feature, grade and extent (out-of-field or in-field) of radiation pneumonitis, oxygenation index, and serum albumin (<35 g/L or >or=35 g/L), and uric acid levels at the onset of radiation pneumonitis. Only the extent of radiation pneumonitis and serum albumin level were independently associated with survival in the multivariate analysis.

Conclusion: The mortality rate of non-small-cell lung cancer patients with severe radiation pneumonitis is extremely high, and survival is much shorter in patients with out-of-field radiation pneumonitis or a low serum albumin level at the onset. Additional studies to investigate the factors precipitating out-of-field radiation pneumonitis should improve the management of irradiation complications.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Analysis of Variance
  • Carcinoma, Non-Small-Cell Lung / mortality*
  • Carcinoma, Non-Small-Cell Lung / radiotherapy
  • Female
  • Humans
  • Lung Neoplasms / mortality*
  • Lung Neoplasms / radiotherapy
  • Male
  • Middle Aged
  • Prognosis
  • Proportional Hazards Models
  • Radiation Pneumonitis / mortality*
  • Radiotherapy Dosage
  • Survival Analysis
  • Treatment Outcome